• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

MarketsandMarkets: Global Stem Cell and Advanced Technologies Market Worth US$ 88.3 Billion By 2014

Posted on: Tuesday, 3 November 2009, 03:30 CST

WILMINGTON, Delaware, November 3 /PRNewswire/ -- The new market research report, 'Global Stem Cell and Advanced Technologies Market' (2009 - 2014)', published by MarketsandMarkets (http://www.marketsandmarkets.com) analyzes the major trends in the global stem cell market. It identifies and analyzes the main market drivers, restraints, and opportunities for the various products, services, technologies, and applications submarkets in different geographic regions.

Browse in-depth TOC on stem cell market. Early buyers will receive 10% customization of report.

http://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-an

d-global-market-48.html

(Due to the length of this URL, it may be necessary to copy and paste the hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and embryo stem cells are expected to drive the growth of the overall market. In addition, intensive R&D efforts and the increasing investments into research on stem cells therapy are soon expected to improve the efficacy of stem cell treatment. However, the high cost of the therapy may affect market growth.

The global stem cell market is estimated to be $88.3 billion by 2014, growing at a CAGR of 14.8 % from 2009 to 2014. The U.S. currently holds a 60% share of the global stem cell market; and forms an especially lucrative market for areas such as bone marrow transplantation through stem cells. This research report will help stakeholders gain a better understanding of product pricing and regulatory framework governing the dynamics of the stem cell market. The key players in the market include Osiris Therapeutics, Stem Tronix Inc., Stemcell Technologies, Genzyme Corp., Cytori, and Geron.

Analyst Briefing Presentation on the Global Stem Cells Market to be held on 18th November, 2009

The Healthcare practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on the Global Stem Cells Market to be held on 18th November, 2009.

To register your participation, please click here

http://www.marketsandmarkets.com/AnalystBriefing/stem-cells-market.asp

About MarketsandMarkets

MarketsandMarkets is a research and consulting firm that publishes 120 market research reports per year. Each strategically analyzed report contains in-depth, five-level segmentation for each of the products, services, applications, technologies, ingredients and stakeholders categories. Our reports also analyze about 200 patents, over 40 companies and micro markets that are mutually exclusive and collectively exhaustive. Browse all our 120 titles at http://www.marketsandmarkets.com.

SOURCE Markets and Markets

Source: PR Newswire

More News in this Category